Potential therapeutic applications of RNA cap analogs
- PMID: 23795970
- DOI: 10.4155/fmc.13.96
Potential therapeutic applications of RNA cap analogs
Abstract
Cap analogs are chemically modified derivatives of the unique cap structure present at the 5´ end of all eukaryotic mRNAs and several non-coding RNAs. Until recently, cap analogs have served primarily as tools in the study of RNA metabolism. Continuing advances in our understanding of cap biological functions (including RNA stabilization, pre-mRNA splicing, initiation of mRNA translation, as well as cellular transport of mRNAs and snRNAs) and the consequences of the disruption of these processes - resulting in serious medical disorders - have opened new possibilities for pharmaceutical applications of these compounds. In this review, the medicinal potential of cap analogs in areas, such as cancer treatment (including eIF4E targeting and mRNA-based immunotherapy), spinal muscular atrophy treatment, antiviral therapy and the improvement of the localization of nucleus-targeting drugs, are highlighted. Advances achieved to date, challenges, plausible solutions and prospects for the future development of cap analog-based drug design are described.
Similar articles
-
mRNA cap analogues substituted in the tetraphosphate chain with CX2: identification of O-to-CCl2 as the first bridging modification that confers resistance to decapping without impairing translation.Nucleic Acids Res. 2017 Sep 6;45(15):8661-8675. doi: 10.1093/nar/gkx569. Nucleic Acids Res. 2017. PMID: 28666355 Free PMC article.
-
Cap and cap-binding proteins in the control of gene expression.Wiley Interdiscip Rev RNA. 2011 Mar-Apr;2(2):277-98. doi: 10.1002/wrna.52. Epub 2010 Oct 28. Wiley Interdiscip Rev RNA. 2011. PMID: 21957010 Review.
-
Synthesis of anti-reverse cap analogs (ARCAs) and their applications in mRNA translation and stability.Methods Enzymol. 2007;431:203-27. doi: 10.1016/S0076-6879(07)31011-2. Methods Enzymol. 2007. PMID: 17923237 Review.
-
High affinity RNA for mammalian initiation factor 4E interferes with mRNA-cap binding and inhibits translation.RNA. 2005 Jan;11(1):77-89. doi: 10.1261/rna.7108205. RNA. 2005. PMID: 15611299 Free PMC article.
-
Novel cap analogs for in vitro synthesis of mRNAs with high translational efficiency.RNA. 2004 Sep;10(9):1479-87. doi: 10.1261/rna.7380904. RNA. 2004. PMID: 15317978 Free PMC article.
Cited by
-
Making the Next Generation of Therapeutics: mRNA Meets Synthetic Biology.ACS Synth Biol. 2023 Sep 15;12(9):2505-2515. doi: 10.1021/acssynbio.3c00253. Epub 2023 Sep 6. ACS Synth Biol. 2023. PMID: 37672348 Free PMC article. Review.
-
mRNA-based cancer therapeutics.Nat Rev Cancer. 2023 Aug;23(8):526-543. doi: 10.1038/s41568-023-00586-2. Epub 2023 Jun 13. Nat Rev Cancer. 2023. PMID: 37311817 Review.
-
Applications of advances in mRNA-based platforms as therapeutics and diagnostics in reproductive technologies.Front Cell Dev Biol. 2023 May 26;11:1198848. doi: 10.3389/fcell.2023.1198848. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37305677 Free PMC article. Review.
-
Design of Cell-Permeable Inhibitors of Eukaryotic Translation Initiation Factor 4E (eIF4E) for Inhibiting Aberrant Cap-Dependent Translation in Cancer.bioRxiv [Preprint]. 2023 May 24:2023.05.23.541912. doi: 10.1101/2023.05.23.541912. bioRxiv. 2023. Update in: J Med Chem. 2023 Aug 10;66(15):10734-10745. doi: 10.1021/acs.jmedchem.3c00917. PMID: 37292917 Free PMC article. Updated. Preprint.
-
Synthesis and Evaluation of Diguanosine Cap Analogs Modified at the C8-Position by Suzuki-Miyaura Cross-Coupling: Discovery of 7-Methylguanosine-Based Molecular Rotors.J Org Chem. 2023 Jun 2;88(11):6827-6846. doi: 10.1021/acs.joc.3c00126. Epub 2023 May 20. J Org Chem. 2023. PMID: 37209102 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
